Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer

Study ID
NCT00004236

Study type
Interventional

Study phase
Phase 2

Study status
Unknown status

Trial Acronym

Trial Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of liposomal doxorubicin in treating patients who have advanced stomach cancer.

More informations

Trial Starting Date

Aug 31,1998

Requirements

Gender All
Minimum age 18 Years
Maximum age N/A

Enrollement Limit